These conversations are valuable not just for their insights into the minds of successful CEOs, but as an ongoing exploration into the nuanced and evolving art of executive leadership.

The shortfall of generic drugs, which comprise the majority of medications that Americans consume, has been a chronic problem, starting well before the mid-2020s.

AstraZeneca, one of 10 drugmakers that have drugs selected for the Medicare price negotiation program, has lost its suit challenging the program, while four more drugmaker lawsuits will be heard this week.

The pending legislation will have little effect on employers' processes, but it's a good reminder about the importance of educating employees about the impacts that life changes, like divorce, may have on their benefits.